Evaluation of BMD Changes in Women with Severe Osteoporosis after Teriparatide Treatment.

被引：0
|
作者：
Malavolta, N. [1 ]
Buffa, A. [1 ]
Vukatana, G. [1 ]
Mule, R. [1 ]
Frigato, M. [1 ]
Migliaccio, S. [2 ]
Iolascon, G. [3 ]
Resmini, G. [4 ]
Borghi, C. [1 ]
机构：
[1] Univ St Orsola Malpighi, Azienda Osped, UOS Reumatol UO Med Interna Borghi, Bologna, Italy
[2] Univ Roma La Sapienza, Rome, Italy
[3] Univ Naples 2, Naples, Italy
[4] Osped Treviglio Caravaggio, Treviglio, Italy
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2008年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S462 / S462
页数：1
相关论文
共 50 条
  • [41] Effect of raloxifene after recombinant teriparatide [hPTH(1–34)] treatment in postmenopausal women with osteoporosis
    S. Adami
    J. San Martin
    M. Muñoz-Torres
    M. J. Econs
    L. Xie
    G. P. Dalsky
    M. McClung
    D. Felsenberg
    J. P. Brown
    M. L. Brandi
    A. Sipos
    [J]. Osteoporosis International, 2008, 19 : 87 - 94
  • [42] First experience with teriparatide as treatment of severe osteoporosis in daily routine in Switzerland
    Krieg, M
    Lamy, O
    Cuenot, S
    Wagener, MD
    [J]. BONE, 2005, 36 : S447 - S447
  • [43] Histomorphometric Changes by Teriparatide in Alendronate Pre-treated Women with Osteoporosis
    Stepan, J. J.
    Dobnig, H.
    Burr, D. B.
    Li, J.
    Ma, Y. L.
    Sipos, A.
    Petto, H.
    Pavo, I.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S6 - S7
  • [44] Teriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis
    Taheri, Saeed
    Fashami, Fatemeh Mirzayeh
    Peiravian, Farzad
    Yousefi, Nazila
    [J]. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (02): : 1073 - 1085
  • [45] Daily or Cyclical Teriparatide Treatment in Women With Osteoporosis on no Prior Therapy and Women on Alendronate
    Cosman, Felicia
    Nieves, Jeri W.
    Zion, Marsha
    Garrett, Patricia
    Neubort, Simon
    Dempster, David
    Lindsay, Robert
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (07): : 2769 - 2776
  • [46] BMD CHANGES IN POSTMENOPAUSAL WOMEN ON IBANDRONATE TREATMENT
    Stefanovska, I.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 166 - 166
  • [47] Mixed-treatment comparison of anabolic (teriparatide and PTH 1-84) therapies in women with severe osteoporosis
    Migliore, A.
    Broccoli, S.
    Massafra, U.
    Bizzi, E.
    Frediani, B.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (03) : 467 - 473
  • [48] Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate
    Miller, Paul D.
    Delmas, Pierre D.
    Lindsay, Robert
    Watts, Nelson B.
    Luckey, Marjorie
    Adachi, Jonathan
    Saag, Kenneth
    Greenspan, Susan L.
    Seeman, Ego
    Boonen, Steven
    Meeves, Suzanne
    Lang, Thomas F.
    Bilezikian, John P.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (10): : 3785 - 3793
  • [49] The effect of teriparatide treatment on quantitative ultrasound in women with established osteoporosis.
    Gonnelli, S
    Martini, G
    Caffarelli, C
    Salvadori, S
    Montagnani, A
    Cadirni, A
    Nuti, R
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S411 - S412
  • [50] Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis
    Chen, Peiqi
    Miller, Paul D.
    Delmas, Pierre D.
    Misurski, Derek A.
    Krege, John H.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (11) : 1785 - 1790
12345